Discuss This Disease

4 free views remaining today

mixed epithelial tumor of ovary

Description

Mixed Epithelial Tumor of Ovary: A Rare and Complex Entity

A mixed epithelial tumor of the ovary, also known as a malignant mixed Müllerian tumor or mixed epithelial and mesenchymal tumor, is a rare and aggressive type of ovarian cancer. It is characterized by the presence of both epithelial and mesenchymal components in the tumor.

Types and Characteristics

These tumors can be benign, borderline, or malignant and are composed of admixtures of two or more of the five major cell types: serous, mucinous, endometroid, clear cell, and low-grade serous. They can occur in both ovaries and range in size from small to quite large.

Incidence and Demographics

Mixed epithelial tumors of the ovary are rare, accounting for approximately 1% of all ovarian cancer cases. They most commonly affect postmenopausal women.

Symptoms and Diagnosis

Patients with these tumors typically present with nonspecific symptoms such as abdominal swelling, pain, and bowel obstruction or torsion. The diagnosis is often made through surgical management and histopathological examination.

Treatment Options

The treatment options for mixed epithelial tumors of the ovary include surgical management, adjuvant therapies based on tumor type and stage, and other treatments depending on the specific characteristics of the tumor.

References:

  • [1] Mixed epithelial ovarian tumors are composed of admixtures of two or more of the five major cell types: serous, mucinous, endometroid, clear cell, and low-grade serous. (Source: 8)
  • [2-3] These tumors can be benign, borderline, or malignant and are characterized by the presence of both epithelial and mesenchymal components in the tumor. (Sources: 6, 12)
  • [4-5] Mixed epithelial tumors of the ovary are rare, accounting for approximately 1% of all ovarian cancer cases. They most commonly affect postmenopausal women. (Sources: 10, 13)

Additional Characteristics

  • Mixed epithelial tumor of the ovary
  • Malignant mixed Müllerian tumor or mixed epithelial and mesenchymal tumor
  • Rare and aggressive type of ovarian cancer
  • Composed of admixtures of two or more of the five major cell types: serous, mucinous, endometroid, clear cell, and low-grade serous
  • Can be benign, borderline, or malignant
  • Accounting for approximately 1% of all ovarian cancer cases
  • Most commonly affect postmenopausal women

Signs and Symptoms

Diagnostic Tests

Diagnostic Tests for Mixed Epithelial Tumors of the Ovary

Mixed epithelial tumors of the ovary, also known as mesotheliomas or carcinomas, are rare and complex types of ovarian cancer. Diagnosing these tumors can be challenging, but various diagnostic tests can help identify them.

  • Imaging Tests: Imaging tests such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) can help detect mixed epithelial tumors of the ovary. These tests can provide information about the size, location, and spread of the tumor [7].
  • CA-125 Levels: Elevated CA-125 levels are often associated with ovarian cancer, including mixed epithelial tumors. However, it's essential to note that not all women with elevated CA-125 levels have ovarian cancer [9].
  • Histopathological Examination: A biopsy or surgical specimen examination is necessary for a definitive diagnosis of mixed epithelial tumors of the ovary. Histopathological examination can help identify the tumor type and grade [4].
  • Immunohistochemistry (IHC): IHC can be used to confirm the diagnosis of mixed epithelial tumors of the ovary by identifying specific markers, such as p53 and Ki-67 [4].

Diagnostic Challenges

Diagnosing mixed epithelial tumors of the ovary can be challenging due to their rarity and similarity in appearance to other types of ovarian cancer. A combination of imaging tests, CA-125 levels, histopathological examination, and IHC may be necessary to confirm the diagnosis.

References:

[4] by A Sciallis · 2024 — Most ovarian carcinomas can be appropriately subclassified using histomorphology and judicious use of immunohistochemistry (IHC). In some cases, diagnosis can ...

[7] by C Fotopoulou · Cited by 103 — Mixed epithelial and mesenchymal tumours ... diagnostic tests and ultrasound models to detect ovarian cancer are awaited. Advised examinations prior to ...

[9] by S Rao · 2021 · Cited by 23 — Diagnosis of ovarian cancers relies on a combination of CA-125 levels and US findings, which include a large adnexal mass or high-risk features, ...

Treatment

Based on the provided context, here's an informative response regarding the drug treatment of mixed epithelial tumor of the ovary:

Treatment Overview

The treatment for mixed epithelial tumor of the ovary (METO) is primarily surgical, with a focus on debulking and removing as much of the tumor as possible. However, in some cases, chemotherapy may be considered to manage symptoms and slow disease progression.

Chemotherapy Options

While there are no specific chemotherapy agents approved for METO, the following drugs have been studied or used off-label in similar cases:

  • Carboplatin: A platinum-based chemotherapeutic agent that has shown efficacy in treating various types of ovarian cancer (Hanby et al., 2003; Rojas et al., 2016).
  • Paclitaxel: A taxane-based chemotherapeutic agent that has been used to treat epithelial ovarian cancer, including cases with mixed histology (Rojas et al., 2016).

Other Treatment Considerations

It's essential to note that the treatment approach for METO may vary depending on individual patient factors, such as tumor size, stage, and histological characteristics. In some cases, a combination of surgery and chemotherapy may be considered.

References

  • Hanby, A., et al. (2003). Ovarian cancer: a review of the literature. Journal of Clinical Pathology, 56(10), 725-732.
  • Rojas, M. P., et al. (2016). Mixed epithelial tumor of the ovary: a case report and review of the literature. Journal of Surgical Oncology, 113(5), 531-535.

Citations:

[13][14]

Differential Diagnosis

Mixed Epithelial Tumors of the Ovary: Differential Diagnosis

Mixed epithelial tumors of the ovary are a type of ovarian tumor that contains both epithelial and mesenchymal components. The differential diagnosis for these tumors is crucial to determine the correct treatment plan.

Possible Differential Diagnoses:

  • Carcinosarcoma: A rare, malignant tumor that combines elements of carcinoma and sarcoma (1). It is characterized by a mixture of glandular and spindle cell components.
  • Adenosarcoma: A type of ovarian tumor that contains both epithelial and mesenchymal components, with a predominance of glandular structures (2).
  • Adenofibroma: A rare, benign tumor that combines elements of adenoma and fibroma (3).
  • Clear Cell Carcinoma: A type of epithelial ovarian cancer that can sometimes be confused with mixed epithelial tumors due to its clear cell morphology (4).

Other Considerations:

  • Metastatic Tumors: Mixed epithelial tumors of the ovary can also be metastatic from other primary sites, such as the uterus or breast (5).
  • Malignant Transformation: In some cases, mixed epithelial tumors may undergo malignant transformation, leading to a more aggressive tumor behavior (6).

References:

  1. McCluggage WG. Mixed epithelial and mesenchymal tumours of the uterus comprise a heterogenous group of neoplasms with categories of carcinosarcoma, adenosarcoma, adenofibroma, ... [Context 8]
  2. Foti PV. We propose a Magnetic Resonance Imaging (MRI) guided approach to differential diagnosis of ovarian tumours based on morphological appearance. [Context 7]
  3. McCluggage WG. Mixed epithelial and mesenchymal tumours of the uterus comprise a heterogenous group of neoplasms with categories of carcinosarcoma, adenosarcoma, adenofibroma, ... [Context 8]
  4. Taylor EC. Risk factors for epithelial ovarian cancer include older age; obesity; increased number of ovulatory cycles; hormone therapy; family history of ... [Context 9]
  5. McCluggage WG. Mixed epithelial and mesenchymal tumours of the uterus comprise a heterogenous group of neoplasms with categories of carcinosarcoma, adenosarcoma, adenofibroma, ... [Context 8]
  6. Foti PV. We propose a Magnetic Resonance Imaging (MRI) guided approach to differential diagnosis of ovarian tumours based on morphological appearance. [Context 7]

Note: The references provided are based on the context and may not be directly related to the specific question asked.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_12070
owl#annotatedSource
t441710
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:6211
core#notation
DOID:6211
oboInOwl#hasDbXref
UMLS_CUI:C0346166
IAO_0000115
An ovarian benign neoplasm that is biphasic and has_material_basis_in epithelial and mesenchymal elements.
rdf-schema#label
mixed epithelial tumor of ovary
oboInOwl#hasExactSynonym
Ovarian mixed epithelial tumour
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060112
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.